194 related articles for article (PubMed ID: 24015244)
1. CD49f(high) cells retain sphere-forming and tumor-initiating activities in human gastric tumors.
Fukamachi H; Seol HS; Shimada S; Funasaka C; Baba K; Kim JH; Park YS; Kim MJ; Kato K; Inokuchi M; Kawachi H; Yook JH; Eishi Y; Kojima K; Kim WH; Jang SJ; Yuasa Y
PLoS One; 2013; 8(8):e72438. PubMed ID: 24015244
[TBL] [Abstract][Full Text] [Related]
2. High CD49f expression is associated with osteosarcoma tumor progression: a study using patient-derived primary cell cultures.
Penfornis P; Cai DZ; Harris MR; Walker R; Licini D; Fernandes JD; Orr G; Koganti T; Hicks C; Induru S; Meyer MS; Khokha R; Barr J; Pochampally RR
Cancer Med; 2014 Aug; 3(4):796-811. PubMed ID: 24802970
[TBL] [Abstract][Full Text] [Related]
3. Sphere-forming cell subpopulations with cancer stem cell properties in human hepatoma cell lines.
Cao L; Zhou Y; Zhai B; Liao J; Xu W; Zhang R; Li J; Zhang Y; Chen L; Qian H; Wu M; Yin Z
BMC Gastroenterol; 2011 Jun; 11():71. PubMed ID: 21669008
[TBL] [Abstract][Full Text] [Related]
4. CD49f-positive cell population efficiently enriches colon cancer-initiating cells.
Haraguchi N; Ishii H; Mimori K; Ohta K; Uemura M; Nishimura J; Hata T; Takemasa I; Mizushima T; Yamamoto H; Doki Y; Mori M
Int J Oncol; 2013 Aug; 43(2):425-30. PubMed ID: 23708747
[TBL] [Abstract][Full Text] [Related]
5. CD49f and CD61 identify Her2/neu-induced mammary tumor-initiating cells that are potentially derived from luminal progenitors and maintained by the integrin-TGFβ signaling.
Lo PK; Kanojia D; Liu X; Singh UP; Berger FG; Wang Q; Chen H
Oncogene; 2012 May; 31(21):2614-26. PubMed ID: 21996747
[TBL] [Abstract][Full Text] [Related]
6. Identification of gastric cancer stem cells using the cell surface marker CD44.
Takaishi S; Okumura T; Tu S; Wang SS; Shibata W; Vigneshwaran R; Gordon SA; Shimada Y; Wang TC
Stem Cells; 2009 May; 27(5):1006-20. PubMed ID: 19415765
[TBL] [Abstract][Full Text] [Related]
7. Trastuzumab (herceptin) targets gastric cancer stem cells characterized by CD90 phenotype.
Jiang J; Zhang Y; Chuai S; Wang Z; Zheng D; Xu F; Zhang Y; Li C; Liang Y; Chen Z
Oncogene; 2012 Feb; 31(6):671-82. PubMed ID: 21743497
[TBL] [Abstract][Full Text] [Related]
8. Isolation and identification of chemotherapy-enriched sphere-forming cells from a patient with gastric cancer.
Bagheri V; Memar B; Behzadi R; Aliakbarian M; Jangjoo A; Bahar MM; Talebi S; Gholamin M; Abbaszadegan MR
J Cell Physiol; 2018 Oct; 233(10):7036-7046. PubMed ID: 29744869
[TBL] [Abstract][Full Text] [Related]
9. Characterization of spheres derived from canine mammary gland adenocarcinoma cell lines.
Michishita M; Akiyoshi R; Yoshimura H; Katsumoto T; Ichikawa H; Ohkusu-Tsukada K; Nakagawa T; Sasaki N; Takahashi K
Res Vet Sci; 2011 Oct; 91(2):254-60. PubMed ID: 21190702
[TBL] [Abstract][Full Text] [Related]
10. CD49f is an efficient marker of monolayer- and spheroid colony-forming cells of the benign and malignant human prostate.
Yamamoto H; Masters JR; Dasgupta P; Chandra A; Popert R; Freeman A; Ahmed A
PLoS One; 2012; 7(10):e46979. PubMed ID: 23071686
[TBL] [Abstract][Full Text] [Related]
11. Analysis of marker-defined HNSCC subpopulations reveals a dynamic regulation of tumor initiating properties.
Bragado P; Estrada Y; Sosa MS; Avivar-Valderas A; Cannan D; Genden E; Teng M; Ranganathan AC; Wen HC; Kapoor A; Bernstein E; Aguirre-Ghiso JA
PLoS One; 2012; 7(1):e29974. PubMed ID: 22276135
[TBL] [Abstract][Full Text] [Related]
12. Human osteosarcoma CD49f(-)CD133(+) cells: impaired in osteogenic fate while gain of tumorigenicity.
Ying M; Liu G; Shimada H; Ding W; May WA; He Q; Adams GB; Wu L
Oncogene; 2013 Sep; 32(36):4252-63. PubMed ID: 23045288
[TBL] [Abstract][Full Text] [Related]
13. Cancer spheres from gastric cancer patients provide an ideal model system for cancer stem cell research.
Han ME; Jeon TY; Hwang SH; Lee YS; Kim HJ; Shim HE; Yoon S; Baek SY; Kim BS; Kang CD; Oh SO
Cell Mol Life Sci; 2011 Nov; 68(21):3589-605. PubMed ID: 21448722
[TBL] [Abstract][Full Text] [Related]
14. Established breast cancer stem cell markers do not correlate with in vivo tumorigenicity of tumor-initiating cells.
Lehmann C; Jobs G; Thomas M; Burtscher H; Kubbies M
Int J Oncol; 2012 Dec; 41(6):1932-42. PubMed ID: 23042145
[TBL] [Abstract][Full Text] [Related]
15. Identification of tumor-initiating cells derived from two canine rhabdomyosarcoma cell lines.
Kishimoto TE; Yashima S; Nakahira R; Onozawa E; Azakami D; Ujike M; Ochiai K; Ishiwata T; Takahashi K; Michishita M
J Vet Med Sci; 2017 Jul; 79(7):1155-1162. PubMed ID: 28529244
[TBL] [Abstract][Full Text] [Related]
16. CD44v8-10 is a cancer-specific marker for gastric cancer stem cells.
Lau WM; Teng E; Chong HS; Lopez KA; Tay AY; Salto-Tellez M; Shabbir A; So JB; Chan SL
Cancer Res; 2014 May; 74(9):2630-41. PubMed ID: 24618343
[TBL] [Abstract][Full Text] [Related]
17. Identification of a subpopulation of long-term tumor-initiating cells in colon cancer.
Peng L; Xiong Y; Wang R; Xiang L; Zhou H; Gu H
Biosci Rep; 2020 Aug; 40(8):. PubMed ID: 32729895
[TBL] [Abstract][Full Text] [Related]
18. CD133(+) gallbladder carcinoma cells exhibit self-renewal ability and tumorigenicity.
Shi CJ; Gao J; Wang M; Wang X; Tian R; Zhu F; Shen M; Qin RY
World J Gastroenterol; 2011 Jun; 17(24):2965-71. PubMed ID: 21734809
[TBL] [Abstract][Full Text] [Related]
19. Epcam, CD44, and CD49f distinguish sphere-forming human prostate basal cells from a subpopulation with predominant tubule initiation capability.
Guo C; Liu H; Zhang BH; Cadaneanu RM; Mayle AM; Garraway IP
PLoS One; 2012; 7(4):e34219. PubMed ID: 22514625
[TBL] [Abstract][Full Text] [Related]
20. Reciprocal regulation by TLR4 and TGF-β in tumor-initiating stem-like cells.
Chen CL; Tsukamoto H; Liu JC; Kashiwabara C; Feldman D; Sher L; Dooley S; French SW; Mishra L; Petrovic L; Jeong JH; Machida K
J Clin Invest; 2013 Jul; 123(7):2832-49. PubMed ID: 23921128
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]